Figure 1.
Schematic representation of the main pathways involved in development of castration-resistant prostate cancer (CRPC). ADT: androgen-deprivation therapy, AR: androgen receptor. Modified from 43.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.